Associated Papers
Effect of ABCG2 genetic polymorphisms on the transport of anti-seizure medications in hCMEC/D3 cell lines.
Bora S et al.
Cytotechnology, 2026
Advancements in Blood Group Genotyping Technology and Clinical Applications.
Liu X et al.
Clinical Chemistry, 2026
Genotype-Driven Resolution of Panagglutination Over a Decade of Korean Rare Blood Program Case Archives.
Kim H et al.
Journal of Clinical Laboratory Analysis, 2026
Synergistic effects of ABCG2 Q141K variant in combination with alcohol consumption and male sex on gout risk in a rare-event Taiwanese cohort.
Lai ZL et al.
Scientific Reports, 2026
Genetic and epigenetic contribution of ABCG2 to gout susceptibility: a case-control study.
Clavijo-Cornejo D et al.
Molecular Biology Reports, 2025
Identification of pathogenic variants in the ABCG2 gene in patients with severe familial hyperuricemia and gout.
Toyoda Y et al.
Molecular and Cellular Biochemistry, 2025
Genetic background of selected hyperuricemia causing gout with pediatric onset.
Stiburkova B et al.
Joint Bone Spine, 2025
First verification of human small intestinal uric acid secretion and effect of ABCG2 polymorphisms.
Miyazaki R et al.
Journal of Translational Medicine, 2025
[Identification of Jr(a-) rare blood type antibodies against anti-Jra: serological and molecular biology analysis and transfusion strategy].
Wu Y et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2025
The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.
Wang LY et al.
Innovation (cambridge (mass.)), 2025
The role of ABCG2 in health and disease: Linking cancer therapy resistance and other disorders.
El-Ashmawy NE et al.
Life Sciences, 2025
Population-specific putative causal variants shape quantitative traits.
Koyama S et al.
Nature Genetics, 2024
The pathogenesis of gout: molecular insights from genetic, epigenomic and transcriptomic studies.
Leask MP et al.
Nature Reviews. Rheumatology, 2024
Genotype Analysis of the JR Blood Group in an East Asian Population Using Tetra-Primer ARMS-PCR.
Song SA et al.
Annals of Clinical and Laboratory Science, 2024
Generation of a human induced pluripotent stem cell line (YUCMi020-A) from peripheral blood mononuclear cells derived from a female with the Jr(a-) blood type.
Cho YK et al.
Stem Cell Research, 2024
Understanding the impact of ABCG2 polymorphisms on drug pharmacokinetics: focus on rosuvastatin and allopurinol.
Kasten A et al.
Expert Opinion on Drug Metabolism & Toxicology, 2024
Biochemical characterization of Jr(a-) blood type-related ABCG2 variants: Arg147Trp and Ser572Arg disrupt the plasma membrane localization of ABCG2.
Toyoda Y et al.
Transfusion, 2024
[Establishment of a genotyping method for the junior blood group and identification of a rare blood type with partial DVI.3 and Jr(a-)].
Liang S et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2024
Prevalence and molecular basis of null blood group phenotypes in the Korean population: Analysis using a public database.
Kim TY et al.
Transfusion, 2024
A whole-exome sequencing study of patent foramen ovale: investigating genetic variants and their association with cardiovascular disorders.
Li X et al.
Frontiers in Genetics, 2024
[Uric Acid Metabolism, Uric Acid Transporters and Dysuricemia].
Ichida K
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan, 2024
Association of ABCG2 Polymorphisms on Triple Negative Breast Cancer (TNBC) Susceptibility Risk.
Hao Ing Y et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2023
Investigation of blood group genotype prevalence in Korean population using large genomic databases.
Bae CO et al.
Scientific Reports, 2023
Hemolytic disease of the newborn due to anti-Jra from a Chinese mother with one novel and one classic heterozygous mutation.
Xiao J et al.
Transfusion Medicine (oxford, England), 2023
Impact of Hyper- and Hypo-Uricemia on Kidney Function.
Miake J et al.
Biomedicines, 2023
Urate Transporter ABCG2 Function and Asymptomatic Hyperuricemia: A Retrospective Cohort Study of CKD Progression.
Ohashi Y et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation, 2023
Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients.
Ohashi Y et al.
Scientific Reports, 2023
The Relationship of Uremic Toxin Indoxyl Sulfate and Intestinal Elimination Mechanisms in Hemodialysis Patients.
Tomášová A et al.
Kidney & Blood Pressure Research, 2023
Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes.
Ohnami S et al.
Scientific Reports, 2022
Impacts of SNPs on adverse events and trough concentration of imatinib in patients with gastrointestinal stromal tumors.
Maekawa K et al.
Drug Metabolism and Pharmacokinetics, 2022
Application of Blood Group Genotyping by Next-Generation Sequencing in Various Immunohaematology Cases.
Kim TY et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie, 2022
Examining an Association of Single Nucleotide Polymorphisms with Hyperuricemia in Chinese Flight Attendants.
Ye J et al.
Pharmacogenomics and Personalized Medicine, 2022
Trends in the Contribution of Genetic Susceptibility Loci to Hyperuricemia and Gout and Associated Novel Mechanisms.
Zhao J et al.
Frontiers in Cell and Developmental Biology, 2022
Substantial anti-gout effect conferred by common and rare dysfunctional variants of URAT1/SLC22A12.
Toyoda Y et al.
Rheumatology (oxford, England), 2021
Aotearoa New Zealand Māori and Pacific Population-amplified Gout Risk Variants: CLNK Is a Separate Risk Gene at the SLC2A9 Locus.
Ji A et al.
The Journal of Rheumatology, 2021
Multidrug efflux transporter ABCG2: expression and regulation.
Kukal S et al.
Cellular and Molecular Life Sciences : Cmls, 2021
Porphyrin accumulation in humans with common dysfunctional variants of ABCG2, a porphyrin transporter: potential association with acquired photosensitivity.
Sakiyama M et al.
Human Cell, 2021
The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
Eckenstaler R et al.
International Journal of Molecular Sciences, 2021
Urate Transporters in the Kidney: What Clinicians Need to Know.
Chung S et al.
Electrolyte & Blood Pressure : E & Bp, 2021
ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?
Bruckmueller H et al.
Expert Opinion on Drug Metabolism & Toxicology, 2021
Medically Important Alterations in Transport Function and Trafficking of ABCG2.
Homolya L
International Journal of Molecular Sciences, 2021
Both variants of A1CF and BAZ1B genes are associated with gout susceptibility: a replication study and meta-analysis in a Japanese population.
Kawaguchi M et al.
Human Cell, 2021
Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
Toyoda Y et al.
International Journal of Molecular Sciences, 2021
Racial Disparity in Drug Disposition in the Digestive Tract.
Gao S et al.
International Journal of Molecular Sciences, 2021
Common germline-somatic variant interactions in advanced urothelial cancer.
Vosoughi A et al.
Nature Communications, 2020
The ABCG2/BCRP transporter and its variants - from structure to pathology.
Sarkadi B et al.
Febs Letters, 2020
Determinants of gefitinib pharmacokinetics in healthy Chinese male subjects: A pharmacogenomic study of cytochrome p450 enzymes and transporters.
Wan Z et al.
Journal of Clinical Pharmacy and Therapeutics, 2020